BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25029513)

  • 1. Novel three-dimensional imaging volumetry in autosomal dominant polycystic kidney disease: comparison with 2D volumetry.
    Shin D; Lee KB; Hyun YY; Lee YR; Hwang YH; Park HC; Ahn C
    Clin Nephrol; 2014 Aug; 82(2):98-106. PubMed ID: 25029513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
    Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
    J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD.
    Caroli A; Villa G; Brambilla P; Trillini M; Sharma K; Sironi S; Remuzzi G; Perico N; Remuzzi A
    Eur Radiol; 2023 Sep; 33(9):6009-6019. PubMed ID: 37017703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
    Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
    Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated measurement of total kidney volume from 3D ultrasound images of patients affected by polycystic kidney disease and comparison to MR measurements.
    Jagtap JM; Gregory AV; Homes HL; Wright DE; Edwards ME; Akkus Z; Erickson BJ; Kline TL
    Abdom Radiol (NY); 2022 Jul; 47(7):2408-2419. PubMed ID: 35476147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
    Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
    Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease.
    Breysem L; De Rechter S; De Keyzer F; Smet MH; Bammens B; Van Dyck M; Hofmans M; Oyen R; Levtchenko E; Mekahli D
    Pediatr Nephrol; 2018 May; 33(5):827-835. PubMed ID: 29306987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
    van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
    J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease.
    Shin JH; Kim YH; Lee MK; Min HS; Cho H; Kim H; Kim YC; Lee YS; Shin TY
    Investig Clin Urol; 2023 May; 64(3):255-264. PubMed ID: 37341005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.
    Turco D; Busutti M; Mignani R; Magistroni R; Corsi C
    Am J Nephrol; 2017; 45(5):373-379. PubMed ID: 28315882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy and processing time of kidney volume measurement methods in rodents polycystic kidney disease models: superiority of semiautomated kidney segmentation.
    Doss MC; Mullen S; Roye R; Zhou J; Chumley P; Mrug E; Wallace DP; Qian F; Harris PC; Yoder BK; Kim H; Mrug M
    Am J Physiol Renal Physiol; 2023 Apr; 324(4):F423-F430. PubMed ID: 36794756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
    van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
    Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisterna chyli in autosomal dominant polycystic kidney disease.
    Thimmappa ND; Blumenfeld JD; Cerilles MA; Dunning A; Donahue SL; Bobb WO; Zhang HL; Prince MR
    J Magn Reson Imaging; 2015 Jan; 41(1):142-8. PubMed ID: 24470398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose.
    Bevilacqua MU; Hague CJ; Romann A; Sheitt H; Vasilescu DM; Yi TW; Levin A
    Radiology; 2019 Jun; 291(3):660-667. PubMed ID: 30964424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease.
    Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT
    J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
    Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
    Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD.
    Cadnapaphornchai MA; Masoumi A; Strain JD; McFann K; Schrier RW
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):369-76. PubMed ID: 21115621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.